NOTCH blockade also makes MM cells more sensitive to standard chemotherapies [39] and to pro-apoptotic compounds such as Bcl-2/Bcl-XL inhibitors [44]. This evidence concerns the gene BCL2L1 and Miyoshi myopathy.